Title : Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA.

Pub. Date : 2017 Jul

PMID : 28580819






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTRODUCTION: Opicapone is a third generation, highly potent and effective catechol O-methyltransferase (COMT) inhibitor that optimizes the pharmacokinetics and bioavailability of L-DOPA therapy. Levodopa catechol-O-methyltransferase Homo sapiens
2 INTRODUCTION: Opicapone is a third generation, highly potent and effective catechol O-methyltransferase (COMT) inhibitor that optimizes the pharmacokinetics and bioavailability of L-DOPA therapy. Levodopa catechol-O-methyltransferase Homo sapiens